The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy

References

• Rolan P, Atkinson AJ, Jr, Lesko LJ. Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development. Clin Pharmacol Ther 2003; 73: 284–91
   PubMed Web of Science ®Google Scholar
• Guyton A. Body temperature, temperature regulation, and fever. Textbook of medical physiology11th ed, AC Guyton, JE Hall. Elsevier, Philadelphia 2006; 889–901
   Google Scholar
• Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15: 81–8
   PubMedGoogle Scholar
• Goscinski G, Lipcsey M, Eriksson M, Larsson A, Tano E, Sjolin J. Endotoxin neutralization and anti-inflammatory effects of tobramycin and ceftazidime in porcine endotoxin shock. Crit Care 2004; 8: R35–41
   Web of Science ®Google Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–54
   PubMed Web of Science ®Google Scholar
• Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990; 8: 253–78
   PubMed Web of Science ®Google Scholar
• Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91: 1351–7
   PubMed Web of Science ®Google Scholar
• Hansson LO, Hedlund JU, Ortqvist AB. Sequential changes of inflammatory and nutritional markers in patients with community-acquired pneumonia. Scand J Clin Lab Invest 1997; 57: 111–8
   PubMed Web of Science ®Google Scholar
• Schmit X, Vincent JL. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 2008; 36: 213–9
   PubMed Web of Science ®Google Scholar
• Silvestre J, Póvoa P, Coelho L, Almeida E, Moreira P, Fernandes A, et al. Is C-reactive protein a good prognostic marker in septic patients?. Intensive Care Med 2009; 35: 909–13
   PubMed Web of Science ®Google Scholar
• Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005; 11: 101–8
   PubMed Web of Science ®Google Scholar
• Viberg A, Lannergard A, Larsson A, Cars O, Karlsson MO, Sandstrom M. A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function. Br J Clin Pharmacol 2006; 62: 297–303
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41
   PubMed Web of Science ®Google Scholar
• Cicarelli, DD, Vieira, JE, Bensenor, FE. Comparison of C-reactive protein and serum amyloid A protein in septic shock patients. Mediators of Inflammation ;2008, Article ID 631414, 5 pages. Available from: URL: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2277077&blobtype=pdf.
   Google Scholar
• Casl MT, Sabljar-Matovinovic M, Kovacevic S, Pocanic D, Preden-Kerekovic V, Jagarinec N. Clinical relevance of serum amyloid A protein monitoring in urinary tract infections. Ann Clin Biochem 1993; 30: 272–7
   PubMed Web of Science ®Google Scholar
• Pizzini C, Mussap M, Plebani M, Fanos V. C-reactive protein and serum amyloid A protein in neonatal infections. Scand J Infect Dis 2000; 32: 229–35
   PubMedGoogle Scholar
• Lannergard A, Larsson A, Friman G, Ewald U. Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in preterm newborn infants with nosocomial infections. Acta Paediatr 2008; 97: 1061–5
   PubMed Web of Science ®Google Scholar
• Engel A, Kern WV, Murdter G, Kern P. Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia. Infection 1994; 22: 160–4
   PubMed Web of Science ®Google Scholar
• Bota DP, Ferreira FL, Mélot C, Vincent JL. Body temperature alterations in the critically ill. Intensive Care Med 2004; 30: 811–6
   PubMed Web of Science ®Google Scholar
• Wilson AP, Treasure T, Grüneberg RN, Sturridge MF, Burridge J. Should the temperature chart influence management in cardiac operations? Result of a prospective study in 314 patients. J Thorac Cardiovasc Surg 1988; 96: 518–23
   PubMed Web of Science ®Google Scholar
• Shaw JA, Chung R. Febrile response after knee and hip arthroplasty. Clin Orthop Relat Res 1999; 367: 181–9
   Google Scholar
• Greisman LA, Mackowiak PA. Fever: beneficial and detrimental effects of antipyretics. Curr Opin Infect Dis 2002; 15: 241–5
   PubMed Web of Science ®Google Scholar
• Mackowiak PA, Plaisacne KI. Benefits and risks of antipyretic therapy. Ann N Y Acad Sci 1998; 856: 214–23
   PubMed Web of Science ®Google Scholar